Global Lipid Contract Manufacturing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04251732

Publication Date:

April 18, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Lipid Contract Manufacturing market size is predicted to grow from US$ 799 million in 2025 to US$ 751 million in 2031; it is expected to grow at a CAGR of -1.0% from 2025 to 2031.
Liposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
The lipid contract manufacturing market is primarily driven by the increasing demand for lipid-based formulations, particularly in the pharmaceutical, biotechnology, and nutraceutical industries. Lipid-based drug delivery systems, such as liposomes, lipid nanoparticles, and micelles, are gaining popularity due to their ability to improve the bioavailability, stability, and targeted delivery of drugs, especially in the treatment of cancer, autoimmune diseases, and other chronic conditions. Additionally, the growing trend of outsourcing production to contract manufacturers helps pharmaceutical and biotechnology companies focus on their core competencies while benefiting from specialized manufacturing expertise, cost efficiency, and scalability. The rise in research and development activities related to lipid formulations further fuels the market growth, as companies seek contract manufacturers with the capability to produce high-quality lipid products at scale.
However, the lipid contract manufacturing market faces challenges related to the complexity and cost of lipid-based formulations. Developing and manufacturing lipid formulations often requires specialized knowledge, sophisticated technology, and stringent quality control processes, which can increase production costs. The market also experiences regulatory challenges, as lipid-based products, particularly those used in drug delivery, need to meet rigorous safety and efficacy standards, which may vary across different regions. Additionally, the scalability of lipid-based production can be a limitation, as certain formulations require careful handling and precision, making large-scale manufacturing more difficult and costly. These factors necessitate continued innovation and investment in advanced manufacturing techniques to overcome these challenges and meet market demands.
Global core lipid contract manufacturing companies include Merck KGaA, Exelead and Avanti Polar Lipids etc. The top 3 companies hold a share about 38%. North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%. In terms of product, lipid nanoparticles is the largest segment with a share about 79%. And in terms of application, the largest application is commercial with a share about 67%, followed by clinical and preclinical.
The 鈥淟ipid Contract Manufacturing Industry Forecast鈥� looks at past sales and reviews total world Lipid Contract Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Contract Manufacturing sales for 2025 through 2031. With Lipid Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Contract Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Lipid Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Lipid Contract Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Contract Manufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Liposomes
Lipid Nanoparticles
Segmentation by Application:
Preclinical
Clinical
Commercial
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lipid Contract Manufacturing Market Size (2020-2031)
2.1.2 Lipid Contract Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Lipid Contract Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Lipid Contract Manufacturing Segment by Type
2.2.1 Liposomes
2.2.2 Lipid Nanoparticles
2.3 Lipid Contract Manufacturing Market Size by Type
2.3.1 Lipid Contract Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Lipid Contract Manufacturing Market Size Market Share by Type (2020-2025)
2.4 Lipid Contract Manufacturing Segment by Application
2.4.1 Preclinical
2.4.2 Clinical
2.4.3 Commercial
2.5 Lipid Contract Manufacturing Market Size by Application
2.5.1 Lipid Contract Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Lipid Contract Manufacturing Market Size Market Share by Application (2020-2025)
3 Lipid Contract Manufacturing Market Size by Player
3.1 Lipid Contract Manufacturing Market Size Market Share by Player
3.1.1 Global Lipid Contract Manufacturing Revenue by Player (2020-2025)
3.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Lipid Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lipid Contract Manufacturing by Region
4.1 Lipid Contract Manufacturing Market Size by Region (2020-2025)
4.2 Global Lipid Contract Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lipid Contract Manufacturing Market Size Growth (2020-2025)
4.4 APAC Lipid Contract Manufacturing Market Size Growth (2020-2025)
4.5 Europe Lipid Contract Manufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Lipid Contract Manufacturing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Lipid Contract Manufacturing Market Size by Country (2020-2025)
5.2 Americas Lipid Contract Manufacturing Market Size by Type (2020-2025)
5.3 Americas Lipid Contract Manufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lipid Contract Manufacturing Market Size by Region (2020-2025)
6.2 APAC Lipid Contract Manufacturing Market Size by Type (2020-2025)
6.3 APAC Lipid Contract Manufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lipid Contract Manufacturing Market Size by Country (2020-2025)
7.2 Europe Lipid Contract Manufacturing Market Size by Type (2020-2025)
7.3 Europe Lipid Contract Manufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lipid Contract Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Lipid Contract Manufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Lipid Contract Manufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lipid Contract Manufacturing Market Forecast
10.1 Global Lipid Contract Manufacturing Forecast by Region (2026-2031)
10.1.1 Global Lipid Contract Manufacturing Forecast by Region (2026-2031)
10.1.2 Americas Lipid Contract Manufacturing Forecast
10.1.3 APAC Lipid Contract Manufacturing Forecast
10.1.4 Europe Lipid Contract Manufacturing Forecast
10.1.5 Middle East & Africa Lipid Contract Manufacturing Forecast
10.2 Americas Lipid Contract Manufacturing Forecast by Country (2026-2031)
10.2.1 United States Market Lipid Contract Manufacturing Forecast
10.2.2 Canada Market Lipid Contract Manufacturing Forecast
10.2.3 Mexico Market Lipid Contract Manufacturing Forecast
10.2.4 Brazil Market Lipid Contract Manufacturing Forecast
10.3 APAC Lipid Contract Manufacturing Forecast by Region (2026-2031)
10.3.1 China Lipid Contract Manufacturing Market Forecast
10.3.2 Japan Market Lipid Contract Manufacturing Forecast
10.3.3 Korea Market Lipid Contract Manufacturing Forecast
10.3.4 Southeast Asia Market Lipid Contract Manufacturing Forecast
10.3.5 India Market Lipid Contract Manufacturing Forecast
10.3.6 Australia Market Lipid Contract Manufacturing Forecast
10.4 Europe Lipid Contract Manufacturing Forecast by Country (2026-2031)
10.4.1 Germany Market Lipid Contract Manufacturing Forecast
10.4.2 France Market Lipid Contract Manufacturing Forecast
10.4.3 UK Market Lipid Contract Manufacturing Forecast
10.4.4 Italy Market Lipid Contract Manufacturing Forecast
10.4.5 Russia Market Lipid Contract Manufacturing Forecast
10.5 Middle East & Africa Lipid Contract Manufacturing Forecast by Region (2026-2031)
10.5.1 Egypt Market Lipid Contract Manufacturing Forecast
10.5.2 South Africa Market Lipid Contract Manufacturing Forecast
10.5.3 Israel Market Lipid Contract Manufacturing Forecast
10.5.4 Turkey Market Lipid Contract Manufacturing Forecast
10.6 Global Lipid Contract Manufacturing Forecast by Type (2026-2031)
10.7 Global Lipid Contract Manufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Lipid Contract Manufacturing Forecast
11 Key Players Analysis
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Information
11.1.2 Precision NanoSystems Lipid Contract Manufacturing Product Offered
11.1.3 Precision NanoSystems Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Precision NanoSystems Main Business Overview
11.1.5 Precision NanoSystems Latest Developments
11.2 Evonik
11.2.1 Evonik Company Information
11.2.2 Evonik Lipid Contract Manufacturing Product Offered
11.2.3 Evonik Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Evonik Main Business Overview
11.2.5 Evonik Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Lipid Contract Manufacturing Product Offered
11.3.3 Merck KGaA Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Information
11.4.2 Genevant Sciences Lipid Contract Manufacturing Product Offered
11.4.3 Genevant Sciences Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Genevant Sciences Main Business Overview
11.4.5 Genevant Sciences Latest Developments
11.5 Exelead
11.5.1 Exelead Company Information
11.5.2 Exelead Lipid Contract Manufacturing Product Offered
11.5.3 Exelead Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Exelead Main Business Overview
11.5.5 Exelead Latest Developments
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Information
11.6.2 Avanti Polar Lipids Lipid Contract Manufacturing Product Offered
11.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Avanti Polar Lipids Main Business Overview
11.6.5 Avanti Polar Lipids Latest Developments
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Information
11.7.2 Nippon Fine Chemical Lipid Contract Manufacturing Product Offered
11.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nippon Fine Chemical Main Business Overview
11.7.5 Nippon Fine Chemical Latest Developments
11.8 Lipoid
11.8.1 Lipoid Company Information
11.8.2 Lipoid Lipid Contract Manufacturing Product Offered
11.8.3 Lipoid Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Lipoid Main Business Overview
11.8.5 Lipoid Latest Developments
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Information
11.9.2 Polymun Scientific Lipid Contract Manufacturing Product Offered
11.9.3 Polymun Scientific Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Polymun Scientific Main Business Overview
11.9.5 Polymun Scientific Latest Developments
11.10 Corden Pharma
11.10.1 Corden Pharma Company Information
11.10.2 Corden Pharma Lipid Contract Manufacturing Product Offered
11.10.3 Corden Pharma Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Corden Pharma Main Business Overview
11.10.5 Corden Pharma Latest Developments
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Information
11.11.2 Acuitas Therapeutics Lipid Contract Manufacturing Product Offered
11.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Acuitas Therapeutics Main Business Overview
11.11.5 Acuitas Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂